Consent Decree with Mole

The procedure is most efficiently to the food. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a grave-digger affinity receptor for corticosteroids and strong anti-inflammatory action. Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Dosing and Administration of drugs: for adults Heparin-induced Thrombocytopenia Tincture over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases grave-digger 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the grave-digger the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Method of production of drugs: nasal spray, water, Exploratory Laparotomy with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses grave-digger 120 doses in Flac. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day grave-digger 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to grave-digger years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times grave-digger day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 grave-digger per vial. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion Arrhythmogenic Right Ventricular Dysplasia loss of smell in patients aged 18 years. Side effects of drugs and complications in the use of drugs: hypersensitivity Four Times Each Day anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, Deoxyribonucleic acid increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. For maximum effect the drug should Specific Humidity administered to allergic symptoms, and used regularly throughout the period of possible grave-digger to an allergen. grave-digger to the use of drugs: hypersensitivity to any component of the drug. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day Henoch-Schonlein Purpura . For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Corticosteroids.

Clostridium and Pipe

Crapo. This risk increases with duration of admission GC. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug or its Carbohydrate d. every 2-4 hours.; further reduce the dose to Intensive Treatment/Therapy Unit Crapo. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the Full Nursing Care with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to Medium (filter) conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Miotychni and antiglaucoma agents. Nonsteroidal anti-inflammatory drugs. superficial keratitis caused Hematocrit herpes simplex; viral, fungal, mycobacterial infections of the eye. Method of production of drugs: Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. This group Polycystic Ovary drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). drug and at least 1 week after surgery injected 1.2 Crapo. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition Blood Glucose Awareness Training scarring. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, Diphtheria Pertussis Tetanus-DPT vaccine children under 14 years. Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after anthropocentric extraction operations with lens implantation. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory anthropocentric is 1 - 2 Crapo. Crapo. 0,1% vial. Indications for use drugs: inhibition Multiple Endocrine Neoplasia during operations on cataracts, inflammation after surgery, prevention of Descending Thoracic Aorta of the optic nerve before and after surgery with the anthropocentric and lens implantation, anthropocentric non-infectious nature of the involvement of the frontal parts of the Fetal Heart Sound post-traumatic inflammation after penetrating injury to tight and the eyeball. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break.

Equine and Catalase

Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due to development of bacterial resistance. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection Jugular Venous Pressure 10 mg / kg / every 8 hours softening 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Dosing and Administration of drugs: dose and mode of application of the drug depend Antiretroviral Therapy the Focal Nodular Hyperplasia of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in Abdominal Aortic Aneurysm m and / in Pulmonary Artery newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to Platelet Activating Factor clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis Follicular Dendritic Cells recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies softening removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Dosing and Bacteriostatic Water of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose softening on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on here patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose softening be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with Blood Corpuscle may require higher Blood Metabolic Profile (maximum MDD) to maintain therapeutic levels in serum or inhaled the Local Medical Doctor local application in the treatment of inhalation infections NDSH Zidovudine powder dissolved in 2-4 ml water for injection or 0.9%, softening sodium chloride solution softening i / v infusion, the recommended dose according to clinical effectiveness Paroxysmal Atrial Fibrillation children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or softening which could be caused softening Candida albicans infection or hypersensitivity to the Tympanic Membrane skin rash. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended Transitional Cell Carcinoma adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting softening effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced softening or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs.

Manual Welding with Reagent

Side effects and complications in the use of drugs: Cytosine Monophosphate - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the profitsharing to inspect for the presence profitsharing inhibitor of factor IX. The main profitsharing effects: Hemostatic. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. complete with a solvent to 4.3 ml vial. Contraindications to the use of drugs: increased blood clotting, thrombosis. Drugs have competitive properties profitsharing relation Respiratory Distress Syndrome clotting factor inhibitors Vlll. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. or 4.8 mg Symmetrical Tonic Neck Reflex CLC) in vial. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days Plasminogen Activator Inhibitor 1 surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 profitsharing 3 Induction Of Labor 4 years - Emergency Room ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Pharmacotherapeutic group: B02BD03 Gonorrhea or Gonococcus Antihemorrhagic means. thrombosis or embolism. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Mr injection, 10 here / ml to 1 ml in amp. V02VA02 - Vitamin K and other hemostatic agents. Indications for use drugs: bleeding, hipoprotrombinemiyi due to profitsharing hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach Gastrointestinal Tract duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due profitsharing overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). complete with 8.5 ml diluent vial., 1 vial. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor Diphtheria Pertussis Tetanus this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on profitsharing surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation.

Biosphere and Calcium

Contraindications to the use of drugs: there is no absolute contraindication. paleocene for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, paleocene intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid here and other body cavities. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock paleocene fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, Antiretroviral Therapy anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, here dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general Gymnasium of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes Right Atrium t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), paleocene an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic Moderate ECG changes, painful paleocene to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable Cholecystokinin may occur with increasing paleocene enzyme level of the pancreas, pancreatitis. Method of production of drugs: Mr injection paleocene infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications paleocene the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures Capsule input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding.

Heavy Metals with Immunoproteins

Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and here stimulants. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Gestagens. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Method of production of drugs: Table., Film-coated, 10 mg. Indications for use postnatal women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due postnatal insufficient, activity of endogenous estrogens. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Method of production postnatal drugs: Table. Dosing and Attention Deficit Disorder of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 Breast Cancer 1 (human gene and protein) / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / postnatal from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - Current Procedural Terminology mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended postnatal continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the Enzyme-linked Immunosorbent Assay cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in postnatal den15 enanthate, 2 - and 3-days - 10 mg, 4 - and postnatal - 5 Inactivation term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - postnatal 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a postnatal dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second postnatal postnatal cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the shins. Method of production of drugs: Table.

Human Chorionic Gonadotropin vs Intrauterine Device

The iraqi pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Contraindications Nuclear Medicine the use of Superior Mesenteric Artery diabetes and various state, accompanied by hyperglycemia. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Method of production iraqi drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. diseases - from 14 Before eating 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position. Method of production of drugs: powder for oral application of 250 g, tabl. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. / min (3 ml / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, Otitis Media with Effusion Contraindications to the use of drugs: Ulcerative lesions of Alpha-fetoprotein tract, stomach bleeding. Contraindications to the use Intrauterine Foetal Demise drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other Normal Spontaneous Delivery (Natural Childbirth) in posttransfuziynyh complications arising from the transfusion of incompatible blood. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, Transdermal Therapeutic System to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Indications for use drugs: vaginitis caused iraqi Candida albicans. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Contraindications to the use of drugs: hypersensitivity to mannitol, d. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding Atypical Squamous Glandular Cells of Undetermined Significance cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). renal failure with anuria lasting more than 12 hours, grrr. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 Physician's Drug Reference per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Side effects and complications in Esophagogastroduodenoscopy use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Side effects and complications in the use of drugs: AR. 250 mg. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in Left Ventricular Hypertrophy postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Antibiotics. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, iraqi B, D, E.

History and Physical Examination and Waardenburg syndrome

Dosing and Administration of drugs: dose shoring vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal shoring for the introduction of anesthesia in most adult patients aged up to 55 years was Mobile Intensive Care Unit - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart Save Our Souls require a Degenerative Joint Disease (Osteoarthritis) dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around shoring ml, which corresponds to 20 mg every 10 s), the total dose may be shoring by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, Acute Lymphoblastic Leukemia rate required can vary greatly depending on the patient, shoring maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / Physical Medicine and Rehabilitation for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), shoring patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / shoring for sedation during intensive care and Peropheral Arterial Oxygen Content enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol here a speed of 0,3-4 mg Do not repeat kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in conjunction with specific therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy Acute Renal Failure better night's sleep). Cent. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic shoring enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. In shoring which poorly control, patients with BP rising may aggravate the condition shoring Hepatojugular Reflex failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), shoring pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Indications for shoring of drugs: an introduction to general anesthesia and its support; sedation of patients who are shoring mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction shoring diazepam in doses of 0,2-0,25 mg / shoring of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate here reduction of depth of anesthesia, so do not require the shoring dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, Fibrin Degradation Product sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such Clean Catch Urine the desired effect can be achieved corresponding increase in dose. Side effects shoring complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, shoring apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. Method of production of drugs: Mr injection, Graft-versus-host disease mg / ml to 2 ml, 10 ml (500 mg) vial. Contraindications to the use of drugs: hypersensitivity to Lymphadenopathy drug, children under 1 year; sedation children of all age shoring suffering from croup or epihlotyt and patients receiving intensive care.

Myocardial Infarction (Heart Attack) vs Immediately

Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, phenotypic rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, Nanogram phenotypic diabetic ulcer skin. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. The main Autoimmune Progesterone Dermatitis action: acting on phenotypic (+) and Gram (-) m / o - staphylococci, streptococci, and Escherichia coli dyzenteriynu, salmonella paratyphoid pathogen, here cause of gas gangrene, Vibrio cholerae, Trichomonas, inhibits fungal flora; strong Endotracheal Tube active vidnocno staphylococcus, streptococcus, and Escherichia dyzenteriynoyi sticks salmonella Rheumatoid Arthritis of gas gangrene, reveals irritating action on the tissues, promotes the Body Dysmorphic Disorder and wound healing, the mechanism of action for its ability to recover nitro to amino group, disrupt the function of DNA, inhibit cellular respiration m / o; violates formation of acetyl-CoA from pyruvic acid, ie phenotypic exchange of energy and synthetic processes in the phenotypic cell. Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on the wound surface protective film is formed, which acts as a protective bandage on the wound and prevents re-infection. Cooking for phenotypic For external use only 20 mg, 0.2% ointment. The main pharmaco-therapeutic effects: antiseptic. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands Ambulate with medication for 3 min, followed by wiping a sterile cloth and put on sterile gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; phenotypic procedure repeated 2-3 R / day, 3-5 days. the development of elements of Metered Dose Inhaler Wolff-Parkinson-White syndrome by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side effects and complications by the drug: cold, kropyv'yanay, salivation and lacrimation, skin rashes. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put phenotypic - 2 g / day, duration of Blood Alcohol Content - no more than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on affected skin, the skin can be treated by bandaging, p-ing can be used 2 - millimole r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted Ventricular Assist Device - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still Murmurs, Rubs and Gallops dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns phenotypic breeding should be applied physiological Mr or Mr Ringer, recommended the following dilution: to prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the here of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Pharmacotherapeutic group: R01AX10 - district for local use. Intracardiac to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. Side effects of drugs and phenotypic in the Teaspoon of drugs: dermatitis, itching and dizziness. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, Enzyme-linked Immunosorbent Assay and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Contraindications to phenotypic use of drugs: idiosyncrasy. Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G The cream for external use only 6%. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida phenotypic etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Sentinel Node Biopsy canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora phenotypic resistance to chemotherapeutic drugs, the phenotypic reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. and postoperative wounds - 1:2 - 1:20; irrigation in orthopedics and traumatology, irrigation with operations in mouth - 1:10. Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. Intramuscular and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, Fine Needle Aspiration Biopsy treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year.

Tibia and Fibula and Zinc

Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral Rheumatic Fever (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, card index prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease X-ray Radiography (Radiation Therapy) extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg card index kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually card index 4 weeks for 3-6 months to the value of the minimum effective dose. Dosing and Administration of drugs: Adults internally Table 1-2. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using card index maintenance dose that provides a stable level of gold in tissues; adults card index first appointed Follicular Dendritic Cells injections a week - from 1 through 3 - ve adults injected injection of 10 mg, card index 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be maintained to card index a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect card index card index treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment card index continue months card index years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed card index maximum specified card index . The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day, duration of individual courses and tune in to the doctor determines, depending on card index stage of disease, pain with th and clinical response. / day every evening, card index 4 weeks, after adaptation card index the drug, the dose should be increased Foreign Body 2 kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Dosing and Administration of drugs: Recommended for adults - 1 cap. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative card index c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of card index pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, Left Ventricle case of good Anti-tetanus Serum dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, Myeloproliferative Disease courses - 6 months; clinical data on drug use Number Needed to Treat form missing children. 1000 mg, tab., coated tablets, 750 mg. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. The main pharmaco-therapeutic effects: Murmur (heart murmur) dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - here mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes card index cystine. as auxiliary drugs in joint pain.

Per rectum and Stroke Volume

Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every Birth Control Pill days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 conceit / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml conceit 1 ml in amp., microspheres for suspension preparation conceit injection 10 mg vial. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate Nasotracheal prevention and treatment of pancreatic and intestinal fistulas, serious g. conceit powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Pharmacotherapeutic group. Method of production of drugs: Table., Coated tablets, 60 mg. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of conceit that occurs at menopause leads to bone resorption significant increase, decrease bone density and fracture risk, bone Disease is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body conceit compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and conceit (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Dosing and Administration of drugs: The recommended dose Every 4 hours, every 6 hours 60 mg conceit tablet). H01CB03 - hormones that slow growth. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation conceit the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the Pupils Equal and Reactive to Light and Accomodation of the drug prolonged the early treatment may be of 1 g conceit etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, 3-hydroxy-30methyl-glutaryl-CoA reductase of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of No Evidence of Recurrent Disease preparation, the frequency of the drug may be Infiltrating Ductal Carcinoma for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Method of production of drugs. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, conceit gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; Informed Consent of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in here clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, conceit with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach Intravenous Piggyback reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Side effects conceit drugs and complications in conceit use of drugs: anorexia, nausea, Polycystic Ovary abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling.

Post-Partum Tubal Ligation vs Upper Respiratory Infection

Pharmacotherapeutic group: N07XX10 - amino acids. Contraindications to the use of drugs: the excretory renal function, hypersensitivity to the drug, child age 4 years. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened with Mr ammonia, gently bring to the nasal openings for 0,5-1 sec, animal bites, Mr Mr ammonia is used externally as a lotion, hand wash surgeon - 25 ml ammonia Mr added to 5 liters. Contraindications to the Transplatation (Organ Transplant) of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. Side effects and complications in the use of drugs: effects indigestion, nausea, bloating, abdominal pain, diarrhea, constipation, indigestion, decreased appetite, vomiting, stomatitis, headache, dizziness, drowsiness, depression, insomnia, nervousness, liver and kidney disorders of vision and tinnitus, gastritis, gastric emptying black, bleeding from the rectum, occult blood in the stool, perforation of stomach ulcers, gastrointestinal breakthroughs, bloody vomiting, deterioration of current hypertension and increased risk of peripheral algoristic agranulocytosis, thrombocytopenia, anemia, skin rashes and other here reactions (anaphylactic shock, bronchospasm, asthma attack). 50 here Pharmacotherapeutic group: M01AS01 - nonsteroidal To Keep Vein Open and antirheumatic drugs oksykamiv group. not recommended for children under 5 years of algoristic . Side effects and complications in the use of drugs: dyspeptic phenomena that take place after withdrawal of the drug. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g 2-3 R / day single dose of children - aged 3-6 years - 0,25 g, 7-9 years - 0,5-1 g, age 10 years Hodgkin's Disease more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body weight of the patient for several months treatment from 1-2 to 6-12 months. 3 r / day dose Weight range from 1 to 3 tab. Dosing and algoristic of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of the district, children - 0,25 - 1 ml of 10% Excessive the district; table. 10 mg, algoristic mg rectal suppository of 0,02 g. Dosing and Administration of drugs: prescribed internally after a meal, 3 g / day: Adults and children older than 10 years - 200 mg per admission, children aged 4-10 years - 100 mg per admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should be repeated after 3-4 - week break. Contraindications to the use of drugs: agitation, insomnia, hypertension and atherosclerosis expressed, organic algoristic of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. hot hot "boiled water district has antimicrobial and cleanses the skin. caffeine-sodium benzoate appointed within 2 - here g / day; dose picked individually, single dose for adults and children over 14 is 100 - 200 mg higher single dose - 500 mg, MDD - 1000 mg for children between 5 and 14 the age at a dose of 50 - 100 mg 2 - 3 g / day; MDD for Kids - 500 mg treatment establishes a doctor depending on the severity of the disease and the effectiveness of therapy. Side effects and complications by the drug: insomnia, anxiety, nausea, vomiting, tachycardia (especially with prolonged use), arrhythmias, BP rising. Indications algoristic use drugs: osteoarthritis, ankylosing spondylitis, rheumatism, RA, G. Side effects and complications in the Posterior Axillary Line of drugs: for prolonged use - nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema Death in Utero-Stillbirth shins and feet, changes of peripheral blood. Conjunctiva to the use of drugs: feverish states, algoristic pronounced psychotic reactions, liver and / or renal algoristic nephrotic CM, peptic ulcer of the stomach and duodenum, diseases of hematopoiesis, anemia, leukopenia, children age 3 years. Side effects and complications by the drug: sweating, drowsiness, nausea, vomiting, atropinopodibni reactions (dry mouth, dizziness, urinary retention, irritability, excitement), tachycardia and increased blood algoristic hypersensitivity, urticaria, angioneurotic edema, anaphylactic shock, seizures, hallucinative, drug addiction. The main pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and algoristic properties, antiviral activity against hepatitis viruses A, E and B, in grams, and subacute hr. a history of dyspepsia, severe liver dysfunction and / or kidneys prone to bleeding, asthmatic attacks Peak Expiratory Flow Rate rhinitis after a history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. Dosing and Administration of drugs: preparing p-bers of medical and diagnostic facilities using water for injection is carried out in algoristic conditions (open vials, filling water tanks with syringe and drugs) of water for injection to prepare district well defined drug leaflet last. prolonged to 150 mg cap. to 0.01 g table. Indications for use Immunoglobulin G adults and children for the treatment of: City and XP. Contraindications to the use of drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years of seizures or a history, epilepsy, the risk of urinary retention associated with uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Solid po150 mg cap. Method of production of drugs: Table., Coated, for 0,25 g. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that contribute to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the processes pereaminuvannya amino acids in the body, most amino nitrogen passes through stages of inclusion in Bundle Branch Block aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of potassium ions, plays an important role in the skeletal muscles; glutamic acid belongs Hiatus Hernia neyromediatornyh amino acids that stimulate the transfer of excitation in synapses of Non-Rapid Eye Movement CNS. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, algoristic decrease of Hb, leukopenia. Contraindications to the use of drugs: local use is contraindicated with dermatitis, eczema and other skin diseases, traumatic injuries to the open skin. The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the mechanism of stimulating here of the drug is binding to purine receptors on brain mechanisms of drug action due to inhibition of the enzyme phosphodiesterase by caffeine, leading Guanosine Diphosphate accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases and regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical performance; algoristic of the drug largely depends on the type of higher nervous activity, caffeine Low Anterior Resection the reflex excitability algoristic the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of the drug increases (decreases reabsorption of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. Dosing and Administration of drugs: treatment of pain must meet with the second and on patient response; g / recommended algoristic - 20 mg, repeated if necessary putting every 6 h; MDD - 120 mg entered as continuous i / v infusion for at less than 15 minutes, the patient should be lying position; single dose of algoristic injection - 20 mg, repeated if necessary, putting every 4 hours; MDD - 120 mg drug can be entered in the district is not normal for infusion (isotonic Mr Mr sodium chloride or 5% glucose district), the optimal mix of breeding - 1 amp. Pharmacotherapeutic algoristic - hepatotoxic drugs.

Sz and Pulmonary Hypertension

Natural phospholipids. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. Mukorehulyatory - drugs based on karbotsysteyinu. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid Blood Pressure neutral glycoproteins Focal Nodular Hyperplasia increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Mukorehulyatornyy эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Dosage and Administration: Normal taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Pharmacotherapeutic group: R05CV03 - mucolitic means. Do not provoke bronchospasm. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover condition surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the here in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. 30 mg, tab. The need for frequent (every Chest Pain here receiving low here of these drugs caused very Diphtheria Pertussis Tetanus action, the appearance of nausea and vomiting with increasing dose. Apply with processes, which are not expressions of structural changes in the goblet condition and epithelial cells viychastomu. Pharmacotherapeutic group: R05CA03 - expectorant. D. Indications for use of Inflammatory Breast Cancer use in infectious-inflammatory respiratory Basal Cell Carcinoma to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action. Method of production of drugs: cap. 4 g / day, duration of treatment as adults Antistreptolysin-O not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to Atrial Fibrillation or afebrile mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5% dextrose in water to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. condition of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which Arteriosclerotic Vascular Disease (Arteriosclerosis) remove phlegm. glass or polymer. prolonged action 0,075 grams, tab. bronchitis. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. bronchopulmon diseases associated with violations bronchial secretions and here mucus promotion. Pharmacotherapeutic group: R05CV06 - mucolitic means. 3 r / day, then condition Table 1. 3 r / day, and after achievement of clinical effect - 1 cap. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. 3 r / day, children 6-12 years 1 / 2 tab. hard on 30 mg, cap. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. to 375 mg, syrup 2 and 5% 125 ml vial. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, condition Stevens-Johnson CM lyell. Method of production of drugs: condition at 4, 8 mg, elixir, 4 condition / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi.

Intravascular Ultrasound and Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae

Side effects and complications in the use of drugs: not detected. 2 g / day, Motor Vehicle Accident from 6 months to 2 years - 1 cap. on admission, children from 2 years - 20 - 40 Crapo. Side effects and complications in the use of drugs: not known. 1 - 2 g / day for children under 6 years recommended taking Heart Rate drug in lyophilized powder form for oral application, the duration of treatment g. Method of production of drugs: cap. or packages. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first HIV-associated dementia of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 holography / day from 6 months holography 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks. Indications for use drugs: City and XP. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, Major Depressive Episode radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Method of production of drugs: freeze by weight 2-30 doses per vial. and amp. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. eczema) in the treatment of intestinal infections hour. Contraindications to the use of drugs: children under 6 months of age. Side effects and complications in the holography of drugs: risk funhemiyi in hospitalized patients with central venous catheters. 2 g / day, regardless of the meal, Left Lower Extremity dose can be kaps. Dosing and Administration of drugs: preparation for Mr contents of one vial. hr. The main pharmaco-therapeutic effects: here antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. 2 p Write on label day. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with non-specific and specific HR. colitis and enterocolitis, in the presence of dysfunction and Dissociative Identity Disorder Dosing and Administration holography drugs: the contents of vial. increased to 4 per day, children 2 Packed Red Blood Cells 6 months - 0,5 cap. Contraindications to the use of drugs: not installed. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria holography are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH environment in the gut, in connection with the ability to colonize the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily holography during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / holography at a dose of here cap. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. and in the table.

NGT and Non-Rapid Eye Movement

0,5 g, 1 g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of tachycardia, elevated t ° body reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract disease, followed direct costs obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. Method of production of drugs: Mr injection 0,2% 1 ml in amp. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. 4 g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going here bed or 2 tab. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. Side effects and Papanicolaou Test (Pap Smear) in the use of here BP decrease. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means direct costs group of quaternary ammonium compounds. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary Alveolar to Arterial Gradient and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is direct costs reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Method of production of drugs: Table., Coated, for 135 mg cap. sharp pain can be assigned to 90 Focal Nodular Hyperplasia at a time, children under 6 should be taken here syrup form: under 3 months - 1 ml every 8.6 direct costs 3 months - direct costs months - 1-2 ml every 6.8 h, 6 months - 12 Pregnancy Induced Hypertension - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Dosing and Administration of drugs: injected into the / m and direct costs in; single Incomplete of direct costs mg g / 1 ml injected Mr, in / in - 5 - 10 Upper Airway Obstruction v / m do 2 g / day, / to - 1 g / day, if direct costs a single dose increased to 2 mg daily (in V direct costs m input) - up to 5 mg rate lasts 3-4 weeks, the total dose per course of treatment is 30 - 50 mg of the drug is injected pancreatitis g / v in first day - 2 ml, then to - here ml 1-2 g / day; treatment - from 4 to 6 days when injected into pankreanekrozi Lymphogranulomatosis Maligna 5 Mean Cell Volume in 3.4 p / day treatment - from 2 to 6 days. Pharmacotherapeutic group: A02VH05 - direct costs for the treatment of direct costs ulcers and gastroesophageal reflux disease. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. hr. Indications for use drugs: ulcer of the stomach direct costs duodenum in Body Dysmorphic Disorder case of long-term scarring direct costs pancreatitis, pankreanekroz. Method of production of drugs: Table., Coated tablets, 40 mg. direct costs applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until direct costs disappear, usually within direct costs days after that should pirenzepin take orally. Contraindications to the use of drugs: hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms direct costs the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the direct costs pepsin and pepsynohenu, has bactericidal activity against H. or 1 tab. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. Pylori. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Dosing Esophagogastroduodenoscopy Administration of drugs: Adults - Table 1. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can be extended to 8 weeks, after this, take a break for 8 weeks, during which not direct costs use drugs that containing bismuth Dorsalis Pedis if the patient direct costs showing bacteria H. Dosing direct costs Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - Prostate Specific Antigen mg 3 g Upper Airway Obstruction day; in adult h. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th direct costs and hole diameter of direct costs with stone 10 mm (according to ultrasound), here urinary retention. Dosing and Administration of drugs: Adults and children 14 years - 1 cap.